Brazil approves Pfizer/BioNTech Covid-19 vaccine for children over 12

RIO DE JANEIRO, BRAZIL – (REUTERS) Brazil health regulator Anvisa on Friday said it had approved the use of the Pfizer/BioNtech Covid-19 vaccine for children over 12 years of age.

Anvisa said it approved the measure after seeing studies, conducted outside Brazil, that showed safety and efficacy for the age group.

The vaccine, the first in Brazil to receive definitive approval from Anvisa, was already authorized for use on adolescents aged 16 and over, the regulator said. It added that the Pfizer vaccine was currently the only one authorized to be used on minors.

Related coverage: Brazil’s Health Minister says Bolsonaro's anti-mask stance is aimed at promting research · U.S. ambassador to Brazil announces unexpected resignation · Brazil Central Bank set for another 0.75% hike; "partial" strategy not enough – Reuters poll · China willing to deepen Covid-19 vaccine cooperation with Brazil

More: Brazil news in English, every day from The Rio Times.

Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error

Brazil runoff, Sunday, October 25: When is the Brazil runoff election. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.